Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2

Status

Unknown 2Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 4

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 12Genitourinary 5Gastrointestinal 5Breast 5Tumor-Agnostic 3Thoracic 3Other solid neoplasm 3Sarcoma 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Biliary Tract Neoplasms 1Adenocarcinoma of the Oesophagus 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × rucaparib × Gastrointestinal × Clear all
NCT02678182 2025-06-10

PLATFORM

Royal Marsden NHS Foundation Trust

Phase 2 Active not recruiting
494 enrolled
Gastrointestinal

Adenocarcinoma of the Oesophagus

NCT03639935 2025-06-03

Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

University of Michigan Rogel Cancer Center

Phase 2 Completed
32 enrolled 14 charts
Gastrointestinal

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT03337087 2024-05-17

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Academic and Community Cancer Research United

Phase 1/2 Unknown
18 enrolled 12 charts
Gastrointestinal

Gastrointestinal Neoplasms, Colorectal Neoplasms

NCT03140670 2023-09-28

Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
46 enrolled 16 charts
Gastrointestinal

Pancreatic Neoplasms

NCT03995017 2023-02-01

RiME

University of Kansas Medical Center

Phase 1/2 Unknown
34 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡